Physician profile
John Richard Doty
NPI 1700816667
$18,053.49
in general payments reported to CMS, 2019-2025
9 companies · $494 in 2025
The $494 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $371 · 2021: $6,620 · 2022: $8,373 · 2023: $1,527 · 2024: $204 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Travel and Lodging: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.56 |
| Travel and Lodging | $1,050.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $9,869.24 | 2019-2022 | |
| Becton, Dickinson and Company | $5,500.00 | 2021 | |
| W. L. Gore & Associates, INC. | $970.09 | 2023-2025 | Gore Tag Thoracic Endoprosthesis, Product In Development, Gore Tag Thoracic Branch Endoprosthesis |
| Artivion, INC. | $581.65 | 2019-2025 | Cardiac Non-Synergraft |
| Medtronic, INC. | $446.09 | 2021-2025 | Endurant Iis, Avalus, Freestyle |
| Edwards Lifesciences Corporation | $394.23 | 2021-2025 | Edwards Intuity Elite Valve System, Konect Resilia |
| Abiomed | $165.47 | 2023 | Impella |
| Bolton Medical INC | $108.07 | 2021-2023 | Treo Abdominal Stent-Graft System |
| Medtronic Vascular, INC. | $18.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.